Mosaic-8 RBD-nanoparticles show promise against current and

A recent study posted to the bioRxiv* preprint server supports using mosaic sarbecovirus receptor-binding domain (RBD)-nanoparticles to discover therapeutic pan-variant and pan-sarbecovirus monoclonal antibodies (mAbs) and to induce mAbs by vaccination.

Related Keywords

, Spytagged Rbds , California Institute Of Technology , Beckman Research Institute Of City Hope , Stanford University , Beckman Research Institute , California Institute , C Terminal Spytag , Cov Chimera , Consurf Database , Coronavirus Disease Covid 19 , Anoparticles , Cars , Ars Cov 2 , Antibodies , Ntibody , B Cell , Fell , Coronavirus , Nzyme , Immunity , Immunization , Anoparticle , Micron , Pandemic , Protein , Eceptor , Research , Espiratory , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome , Vaccine ,